MCID: PST027
MIFTS: 45

Postencephalitic Parkinson Disease

Categories: Neuronal diseases, Rare diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Postencephalitic Parkinson Disease

MalaCards integrated aliases for Postencephalitic Parkinson Disease:

Name: Postencephalitic Parkinson Disease 11 14 16
Postencephalitic Parkinsonism 11 58 53 31
Parkinson Disease, Postencephalitic 43 71

Classifications:

Orphanet: 58  
Rare neurological diseases


Summaries for Postencephalitic Parkinson Disease

MalaCards based summary: Postencephalitic Parkinson Disease, also known as postencephalitic parkinsonism, is related to corticobasal degeneration and tremor. An important gene associated with Postencephalitic Parkinson Disease is MAPT (Microtubule Associated Protein Tau), and among its related pathways/superpathways are Neuroscience and Dopaminergic neurogenesis. Affiliated tissues include eye, brain and cortex, and related phenotypes are resting tremor and fever

Related Diseases for Postencephalitic Parkinson Disease

Diseases related to Postencephalitic Parkinson Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 145)
# Related Disease Score Top Affiliating Genes
1 corticobasal degeneration 30.6 TARDBP MAPT
2 tremor 30.4 SNCA PRKN MAPT LRRK2
3 von economo's disease 30.4 SNCA SLC6A3 LRRK2 IGLON5 ACE2
4 striatonigral degeneration 29.9 TH SNCA SLC6A3 LRRK2
5 oculogyric crisis 29.8 TH SLC6A3 SLC25A11
6 creutzfeldt-jakob disease 29.6 TARDBP SNCA MAPT LRRK2 APP
7 early-onset parkinson's disease 29.5 SNCA SLC6A3 PRKN PINK1 PARK7 LRRK2
8 parkinsonism 29.3 TH TARDBP SNCA SLC6A3 PRKN PINK1
9 attention deficit-hyperactivity disorder 29.1 TH SNCA SLC6A3 MAPT MAOB APP
10 dystonia 28.9 TH SNCA SLC6A3 PRKN PINK1 PARK7
11 multiple system atrophy 1 28.6 TH SNCA SLC6A3 PRKN PINK1 PARK7
12 supranuclear palsy, progressive, 1 28.4 TH TARDBP SNCA SLC6A3 PRKN PINK1
13 parkinson disease, late-onset 28.3 TH SNCA SLC6A3 PRKN PINK1 PARK7
14 dementia 28.2 TH TARDBP SNCA SLC6A3 PRKN PINK1
15 dementia, lewy body 28.1 TH TARDBP SNCA SLC6A3 PRKN PINK1
16 alzheimer disease, familial, 1 28.0 TH TARDBP SNCA SLC6A3 PRKN PINK1
17 movement disease 27.8 TH TARDBP SNCA SLC6A3 PRKN PINK1
18 encephalitis 10.5
19 papillon-lefevre syndrome 10.4
20 finger agnosia 10.3 SLC6A3 MAPT
21 coenzyme q10 deficiency, primary, 1 10.2 SNCA MAPT
22 parkinson disease 1, autosomal dominant 10.2 SNCA LRRK2
23 associative agnosia 10.2 TARDBP MAPT
24 gerstmann syndrome 10.2 TARDBP MAPT
25 juvenile-onset parkinson's disease 10.2 SNCA PRKN
26 simultanagnosia 10.2 TARDBP MAPT
27 parkinson disease 21 10.2 PRKN LRRK2
28 alexia 10.2 TARDBP MAPT
29 inclusion body myopathy with early-onset paget disease of bone with or without frontotemporal dementia 2 10.2 TARDBP MAPT
30 prosopagnosia 10.2 TARDBP MAPT
31 dysgraphia 10.2 TARDBP MAPT
32 intellectual developmental disorder, autosomal dominant 55, with seizures 10.2 SNCA MAPT LRRK2
33 capgras syndrome 10.2 SNCA SLC6A3 MAPT
34 hereditary late-onset parkinson disease 10.2 SNCA MAPT LRRK2
35 viral encephalitis 10.2
36 epilepsy, idiopathic generalized 2 10.1 TARDBP MAPT
37 lingual-facial-buccal dyskinesia 10.1 SLC6A3 IGLON5
38 mutism 10.1 SLC6A3 MAPT IGLON5
39 binswanger's disease 10.1 MAPT APP
40 nominal aphasia 10.1 TARDBP SNCA MAPT
41 visual agnosia 10.1 MAPT APP
42 pseudobulbar palsy 10.1 TARDBP SNCA MAPT
43 parkinson disease 6, autosomal recessive early-onset 10.1 PINK1 PARK7
44 echolalia 10.1 SLC6A3 MAPT
45 perry syndrome 10.1 TARDBP SNCA MAPT
46 agraphia 10.1 TARDBP SLC6A3 MAPT
47 dissociated nystagmus 10.1 TH SLC6A3
48 pure autonomic failure 10.1 SNCA MAOB
49 writing disorder 10.1 TARDBP SLC6A3 MAPT
50 pathological gambling 10.1 SLC6A3 MAOB

Graphical network of the top 20 diseases related to Postencephalitic Parkinson Disease:



Diseases related to Postencephalitic Parkinson Disease

Symptoms & Phenotypes for Postencephalitic Parkinson Disease

Human phenotypes related to Postencephalitic Parkinson Disease:

58 30 (show all 45)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 resting tremor 58 30 Hallmark (90%) Very frequent (99-80%)
HP:0002322
2 fever 58 30 Frequent (33%) Frequent (79-30%)
HP:0001945
3 babinski sign 58 30 Frequent (33%) Frequent (79-30%)
HP:0003487
4 generalized muscle weakness 58 30 Frequent (33%) Frequent (79-30%)
HP:0003324
5 poor speech 58 30 Frequent (33%) Frequent (79-30%)
HP:0002465
6 cogwheel rigidity 58 30 Frequent (33%) Frequent (79-30%)
HP:0002396
7 drowsiness 58 30 Frequent (33%) Frequent (79-30%)
HP:0002329
8 bradykinesia 58 30 Frequent (33%) Frequent (79-30%)
HP:0002067
9 oculogyric crisis 58 30 Frequent (33%) Frequent (79-30%)
HP:0010553
10 dysarthria 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0001260
11 dysphagia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002015
12 kyphosis 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002808
13 vomiting 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002013
14 open mouth 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0000194
15 paresthesia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0003401
16 cough 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0012735
17 headache 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002315
18 hyperactive deep tendon reflexes 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0006801
19 auditory hallucinations 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0008765
20 akinesia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002304
21 happy demeanor 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0040082
22 abnormal aggressive, impulsive or violent behavior 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0006919
23 slow saccadic eye movements 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0000514
24 bilateral ptosis 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0001488
25 upgaze palsy 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0025331
26 tremor by anatomical site 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0030188
27 fixed facial expression 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0005329
28 abnormal csf protein level 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0025456
29 camptocormia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0100595
30 csf lymphocytic pleiocytosis 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0200149
31 aphasia 30 Occasional (7.5%) HP:0002381
32 seizure 30 Occasional (7.5%) HP:0001250
33 depression 30 Occasional (7.5%) HP:0000716
34 abnormal substantia nigra morphology 30 Occasional (7.5%) HP:0045007
35 seizures 58 Occasional (29-5%)
36 abnormal pyramidal sign 58 Frequent (79-30%)
37 abnormality of eye movement 58 Occasional (29-5%)
38 depressivity 58 Occasional (29-5%)
39 dysphasia 58 Occasional (29-5%)
40 involuntary movements 58 Frequent (79-30%)
41 rigidity 58 Occasional (29-5%)
42 abnormality of higher mental function 58 Occasional (29-5%)
43 functional respiratory abnormality 58 Occasional (29-5%)
44 diminished movement 58 Occasional (29-5%)
45 abnormality of the substantia nigra 58 Occasional (29-5%)

MGI Mouse Phenotypes related to Postencephalitic Parkinson Disease:

45 (show all 12)
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 10.22 APP LRRK2 MAOB MAPT PARK7 PINK1
2 homeostasis/metabolism MP:0005376 10.21 ACE2 APP LRRK2 MAOB MAPT PARK7
3 cellular MP:0005384 10.15 ACE2 APP LRRK2 MAOB MAPT PARK7
4 growth/size/body region MP:0005378 10.14 ACE2 APP IGLON5 MAPT PARK7 PINK1
5 no phenotypic analysis MP:0003012 10.1 APP LRRK2 MAPT PINK1 PRKN SNCA
6 behavior/neurological MP:0005386 10.06 APP LRRK2 MAOB MAPT PARK7 PINK1
7 normal MP:0002873 10.05 APP LRRK2 MAPT PRKN SLC6A3 SNCA
8 renal/urinary system MP:0005367 10 ACE2 IGLON5 LRRK2 MAOB MAPT SNCA
9 skeleton MP:0005390 9.86 APP LRRK2 PARK7 PINK1 PRKN SLC6A3
10 mortality/aging MP:0010768 9.73 ACE2 APP IGLON5 LRRK2 MAPT PINK1
11 taste/olfaction MP:0005394 9.46 MAPT PINK1 SLC6A3 SNCA
12 integument MP:0010771 9.28 ACE2 APP IGLON5 LRRK2 MAPT PRKN

Drugs & Therapeutics for Postencephalitic Parkinson Disease

Search Clinical Trials, NIH Clinical Center for Postencephalitic Parkinson Disease

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Scopolamine
Scopolamine Hydrobromide

Cochrane evidence based reviews: parkinson disease, postencephalitic

Genetic Tests for Postencephalitic Parkinson Disease

Anatomical Context for Postencephalitic Parkinson Disease

Organs/tissues related to Postencephalitic Parkinson Disease:

MalaCards : Eye, Brain, Cortex, Skin

Publications for Postencephalitic Parkinson Disease

Articles related to Postencephalitic Parkinson Disease:

(show top 50) (show all 161)
# Title Authors PMID Year
1
Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. 53 62
10090668 1999
2
Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. 53 62
9307257 1997
3
Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis. 62
34454938 2021
4
No Metagenomic Evidence of Causative Viral Pathogens in Postencephalitic Parkinsonism Following Encephalitis Lethargica. 62
34442795 2021
5
Spotlight on Oculogyric Crisis: A Review. 62
34349300 2021
6
The first psychiatric pandemic: Encephalitis lethargica, 1917-27. 62
33268001 2021
7
"You Are Older, although You Do Not Know That": Time, Consciousness, and Memory in "A Kind of Alaska" by Harold Pinter (1930-2008). 62
34284399 2021
8
Centenary of Tretiakoff's thesis on the morphology of Parkinson's disease, evolved on the grounds of encephalitis lethargica pathology. 62
31226240 2019
9
The centennial lesson of encephalitis lethargica. 62
29555881 2018
10
Von Economo's disease and postencephalitic parkinsonism responsive to carbidopa and levodopa. 62
29670352 2018
11
Powassan virus postencephalitic parkinsonism. 62
29431163 2017
12
Olfactory vector hypothesis for encephalitis lethargica. 62
28571798 2017
13
Oculogyric crises: Etiology, pathophysiology and therapeutic approaches. 62
27964831 2017
14
Psychosis in parkinsonism: an unorthodox approach. 62
28553118 2017
15
Russell Meyers (1905-1999): pioneer of functional and ultrasonic neurosurgery. 62
26871378 2016
16
Poster 319 Response of Postencephalitic Parkinsonism to Various Dopaminergic Agonists: A Case Report. 62
27673072 2016
17
Enteroviral Postencephalitic Parkinsonism With Evidence of Impaired Presynaptic Dopaminergic Function. 62
27367905 2016
18
Postencephalitic parkinsonism responsive to a dopamine agonist: A case report. 62
25899543 2015
19
Postencephalitic parkinsonism and selective involvement of substantia nigra. 62
25577509 2015
20
Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood. 62
24745788 2015
21
The medical treatment of Parkinson disease from James Parkinson to George Cotzias. 62
25491387 2015
22
Postencephalitic parkinsonism: interesting clinico-imaging correlation. 62
24993469 2014
23
Parkinson's disease presenting with oculogyric crisis in the off period. 62
24694499 2014
24
Centenary of Lewy bodies (1912-2012). 62
23456291 2013
25
Etiologies of Parkinsonism in a century-long autopsy-based cohort. 62
22702335 2013
26
The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease. 62
23853734 2013
27
Association of Parkinson's disease with infections and occupational exposure to possible vectors. 62
22753266 2012
28
Effect of deep brain stimulation on postencephalitic parkinsonism: a case report. 62
22555963 2012
29
The Wilson films--post encephalitic Parkinsonism. 62
22170267 2011
30
A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel Alexander Kinnier Wilson. 62
21370261 2011
31
Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection. 62
21519006 2011
32
The diagnosis of postencephalitic parkinsonism at the neurological unit of Boston City Hospital, 1930-1981. 62
21327402 2011
33
Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism? 62
20629127 2010
34
A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship. 62
20629120 2010
35
Rosenow's rabbits and postencephalitic parkinsonism. 62
19822874 2009
36
Absence of alpha-synuclein pathology in postencephalitic parkinsonism. 62
19404653 2009
37
Constantin von Economo's contribution to the understanding of movement disorders. 62
17290463 2007
38
West Nile virus encephalomyelitis with polio-like paralysis & nigral degeneration. 62
17168167 2006
39
Topographic study of Alzheimer's neurofibrillary changes: a personal perspective. 62
16914844 2006
40
Movement disorders associated with encephalitis lethargica: a video compilation. 62
16200538 2006
41
Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? 62
15022178 2004
42
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. 62
14502653 2003
43
Dementia with Lewy bodies and the neurobehavioral decline of Mervyn Peake. 62
12810496 2003
44
Unexplained sudden amnesia, postencephalitic Parkinson disease, subacute sclerosing panencephalitis, and Alzheimer disease: does viral synergy produce neurofibrillary tangles? 62
12707087 2003
45
A fatal case of coxsackievirus B4 meningoencephalitis. 62
12533096 2003
46
Friedrich Heinrich Lewy (1885-1950) and his work. 62
12012571 2002
47
von Economo encephalitis. 62
11594935 2001
48
An autopsy case of postencephalitic parkinsonism of von Economo type: some new observations concerning neurofibrillary tangles and astrocytic tangles. 62
10935451 2000
49
Parkinsonism, dementia and vertical gaze palsy in a Guamanian with atypical neuroglial degeneration. 62
10651031 2000
50
Neuropsychiatry of Huntington's disease and other basal ganglia disorders. 62
10665265 2000

Variations for Postencephalitic Parkinson Disease

Expression for Postencephalitic Parkinson Disease

Search GEO for disease gene expression data for Postencephalitic Parkinson Disease.

Pathways for Postencephalitic Parkinson Disease

Pathways related to Postencephalitic Parkinson Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 12.34 TH TARDBP SNCA PRKN PINK1 PARK7
2 10.91 TH SLC6A3
3 10.85 TH SNCA SLC6A3 PRKN PARK7 MAOB
4
Show member pathways
10.79 TH SLC6A3 MAOB
5 10.77 APP ACE2
6 10.75 TH SNCA SLC6A3 PRKN PINK1 PARK7
7 10.62 TH MAOB
8 10.44 TH MAOB

GO Terms for Postencephalitic Parkinson Disease

Cellular components related to Postencephalitic Parkinson Disease according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 mitochondrion GO:0005739 10.32 TH TARDBP SNCA SLC25A11 PRKN PINK1
2 perinuclear region of cytoplasm GO:0048471 10.27 APP PARK7 PINK1 PRKN SNCA TH
3 neuronal cell body GO:0043025 10.13 TH SNCA SLC6A3 MAPT LRRK2
4 mitochondrial outer membrane GO:0005741 10.11 PRKN PINK1 MAOB LRRK2
5 growth cone GO:0030426 10.02 APP LRRK2 MAPT PINK1 SNCA
6 cell body GO:0044297 10 PINK1 PARK7 MAPT
7 synapse GO:0045202 10 TH SNCA PRKN PARK7 LRRK2 APP
8 membrane raft GO:0045121 9.93 ACE2 APP LRRK2 MAPT PARK7 SLC6A3
9 Golgi-associated vesicle GO:0005798 9.86 LRRK2 APP
10 cell projection GO:0042995 9.86 TH SNCA SLC6A3 PRKN MAPT LRRK2
11 astrocyte projection GO:0097449 9.85 PINK1 APP
12 Lewy body GO:0097413 9.73 PRKN PINK1
13 neuron projection GO:0043005 9.73 TH SLC6A3 PRKN PARK7 MAPT LRRK2
14 dopaminergic synapse GO:0098691 9.71 SLC6A3 PRKN
15 main axon GO:0044304 9.71 MAPT APP
16 axon GO:0030424 9.53 TH SNCA SLC6A3 PINK1 PARK7 MAPT

Biological processes related to Postencephalitic Parkinson Disease according to GeneCards Suite gene sharing:

(show top 50) (show all 59)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of gene expression GO:0010629 10.26 APP MAPT PARK7 PINK1 PRKN TARDBP
2 response to xenobiotic stimulus GO:0009410 10.25 MAOB SLC6A3 SNCA TH
3 negative regulation of neuron apoptotic process GO:0043524 10.23 SNCA PRKN PINK1 PARK7
4 regulation of protein stability GO:0031647 10.18 TARDBP PRKN LRRK2
5 regulation of autophagy GO:0010506 10.18 PRKN MAPT LRRK2
6 positive regulation of protein binding GO:0032092 10.18 PRKN LRRK2 APP
7 cellular response to oxidative stress GO:0034599 10.17 SNCA PINK1 PARK7 LRRK2
8 positive regulation of peptidyl-serine phosphorylation GO:0033138 10.16 APP PARK7 PINK1 SNCA
9 learning GO:0007612 10.15 TH PRKN APP
10 synapse organization GO:0050808 10.15 SNCA MAPT APP
11 mitochondrion organization GO:0007005 10.14 PRKN PINK1 PARK7 LRRK2
12 response to oxidative stress GO:0006979 10.13 APP LRRK2 PARK7 PINK1 PRKN
13 autophagy GO:0006914 10.12 PRKN PINK1 PARK7 LRRK2
14 negative regulation of protein phosphorylation GO:0001933 10.11 TARDBP PRKN PARK7 LRRK2
15 adult locomotory behavior GO:0008344 10.1 APP PARK7 PRKN SNCA
16 locomotory behavior GO:0007626 10.09 TH SLC6A3 PRKN APP
17 regulation of mitochondrial membrane potential GO:0051881 10.08 PRKN PINK1 PARK7
18 microglial cell activation GO:0001774 10.07 SNCA MAPT APP
19 cellular response to dopamine GO:1903351 10.03 PRKN LRRK2
20 negative regulation of autophagosome assembly GO:1902902 10.02 PINK1 LRRK2
21 positive regulation of peptidase activity GO:0010952 10.02 APP PINK1
22 negative regulation of macroautophagy GO:0016242 10.02 LRRK2 PINK1
23 response to corticosterone GO:0051412 10.02 MAOB TH
24 astrocyte activation GO:0048143 10.01 MAPT APP
25 supramolecular fiber organization GO:0097435 10.01 SNCA MAPT
26 regulation of dopamine metabolic process GO:0042053 10 PRKN SLC6A3
27 negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236 10 LRRK2 PARK7 PRKN
28 negative regulation of hydrogen peroxide-induced cell death GO:1903206 9.99 PARK7 LRRK2
29 regulation of cellular response to oxidative stress GO:1900407 9.99 PRKN PINK1
30 protein localization to mitochondrion GO:0070585 9.99 PRKN LRRK2
31 dopamine catabolic process GO:0042420 9.99 SLC6A3 MAOB
32 regulation of mitochondrial fission GO:0090140 9.98 LRRK2 MAPT
33 cellular response to toxic substance GO:0097237 9.98 PINK1 PRKN
34 regulation of transmembrane transporter activity GO:0022898 9.97 ACE2 SNCA
35 regulation of locomotion GO:0040012 9.97 LRRK2 SNCA
36 regulation of reactive oxygen species metabolic process GO:2000377 9.97 SNCA PRKN PINK1
37 negative regulation of neuron death GO:1901215 9.97 LRRK2 PARK7 PINK1 PRKN SNCA
38 intracellular distribution of mitochondria GO:0048312 9.96 LRRK2 MAPT
39 regulation of protein targeting to mitochondrion GO:1903214 9.96 PINK1 PRKN
40 positive regulation of autophagy of mitochondrion GO:1903599 9.96 PARK7 PRKN
41 hyaloid vascular plexus regression GO:1990384 9.95 SLC6A3 TH
42 mating behavior GO:0007617 9.95 TH APP
43 positive regulation of histone deacetylase activity GO:1901727 9.94 LRRK2 PINK1
44 positive regulation of mitophagy in response to mitochondrial depolarization GO:0098779 9.93 PRKN PINK1
45 dopamine biosynthetic process GO:0042416 9.93 TH SNCA SLC6A3
46 negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway GO:1903377 9.92 PRKN PARK7
47 negative regulation of mitochondrial fission GO:0090258 9.92 PINK1 MAPT
48 mitochondrion to lysosome transport GO:0099074 9.91 PINK1 PRKN
49 positive regulation of mitochondrial electron transport, NADH to ubiquinone GO:1902958 9.91 PARK7 PINK1
50 dopamine metabolic process GO:0042417 9.89 PRKN SNCA

Molecular functions related to Postencephalitic Parkinson Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 tubulin binding GO:0015631 9.72 PRKN MAPT LRRK2
2 peptidase activator activity GO:0016504 9.67 PINK1 APP
3 enzyme binding GO:0019899 9.65 APP MAPT PARK7 PRKN TH
4 identical protein binding GO:0042802 9.6 TH TARDBP SNCA PRKN PARK7 MAPT
5 cuprous ion binding GO:1903136 9.56 SNCA PARK7
6 dopamine binding GO:0035240 9.46 TH SLC6A3

Sources for Postencephalitic Parkinson Disease

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 24-Oct-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....